HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Allergy & Immunology
Advisory committee recommends resuming Janssen COVID-19 vaccination for adults, citing benefits over risks
Health officials update recommendations for Johnson & Johnson COVID-19 vaccine
A U.S. advisory committee issued updated recommendations for the Janssen COVID-19 vaccine for persons aged ≥18 years. The committee conclude…
Health officials keep the Johnson & Johnson COVID-19 vaccine available for adults but add a warning about rare clotting risks for women aged…
CDC
Apr 4, 2026
Allergy & Immunology
ACIP issues interim recommendation for Pfizer COVID-19 vaccine in adolescents aged 12-15
Health panel issues interim recommendation for Pfizer COVID-19 vaccine in adolescents
The Advisory Committee on Immunization Practices issued an interim recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in adolesc…
A U.S. health advisory committee recommends the Pfizer COVID-19 vaccine for adolescents aged 12-15 to help prevent the virus.
CDC
Apr 4, 2026
Allergy & Immunology
ACIP Recommends Moderna COVID-19 Vaccine for Adults Aged 18 Years and Older
What does the CDC's vaccine committee recommend for adults getting Moderna's COVID shot?
The Advisory Committee on Immunization Practices (ACIP) has issued a recommendation for use of the Moderna COVID-19 vaccine in adults aged ≥…
The CDC's vaccine committee officially recommends adults 18 and older in the United States receive the Moderna COVID-19 shot.
CDC
Apr 4, 2026
Pediatrics
Safety monitoring report examines Pfizer-BioNTech booster vaccination in adolescents aged 12-17
U.S. monitors safety of Pfizer COVID-19 booster shots in adolescents aged 12-17
A safety monitoring report from the United States describes post-authorization surveillance of the Pfizer-BioNTech COVID-19 booster in adole…
U.S. health officials are monitoring the safety of Pfizer COVID-19 booster shots in children and teenagers aged 12 to 17 years.
CDC
Apr 4, 2026
Pediatrics
COVID-NET report describes COVID-19 hospitalization rates in infants and children aged 0-4 years
Report describes COVID-19 hospitalization rates in young children under age 5
An observational report from the COVID-NET network describes COVID-19 hospitalization rates among infants and children aged 0-4 years with l…
A public health report describes COVID-19 hospitalization rates in infants and children aged 0-4 years, including during the Omicron variant…
CDC
Apr 4, 2026
Pediatrics
Report examines COVID-19 vaccine provider availability and coverage in US children aged 5-11
Report examines COVID-19 vaccine access for children and how it relates to vaccination rates
A report examined the relationship between COVID-19 vaccine provider availability and vaccination coverage among children aged 5-11 years in…
A new report links how easy it is for families to find COVID-19 vaccine spots with higher vaccination rates among children aged 5 to 11 acro…
CDC
Apr 4, 2026
OB/GYN & Women's Health
Observational study finds pregnant women with SARS-CoV-2 infection more likely to need ICU care and ventilation
Does COVID-19 hit pregnant women harder? New data suggests it might.
An observational study of pregnant and nonpregnant women with laboratory-confirmed SARS-CoV-2 infection in the United States found pregnant …
Pregnant women with confirmed COVID-19 are more likely to require intensive care unit admission and mechanical ventilation than nonpregnant …
CDC
Apr 4, 2026
Allergy & Immunology
ACIP Recommends Pfizer-BioNTech COVID-19 Vaccine for Children Aged 5-11 Years
CDC advisory panel recommends Pfizer COVID-19 vaccine for children ages 5 to 11
The ACIP has issued a recommendation for the Pfizer-BioNTech COVID-19 vaccine in children aged 5-11 years in the United States. No study typ…
A CDC advisory panel now recommends the Pfizer COVID-19 vaccine for children ages 5 to 11 years in the United States.
CDC
Apr 4, 2026
Allergy & Immunology
Observational report finds low COVID-19 vaccination coverage among US children and adolescents
Why are so few US kids getting their COVID-19 shots?
An observational report on COVID-19 vaccination coverage among US children and adolescents aged 5-17 years found overall low coverage. Paren…
Overall low COVID-19 vaccination coverage among children and adolescents 5-17 years old and parental intent to vaccinate their child.
CDC
Apr 4, 2026
Pediatrics
COVID-19 pandemic effects on routine pediatric vaccine ordering and administration in the US
Report examines how the COVID-19 pandemic affected routine childhood vaccinations
An observational report describes the impact of the COVID-19 pandemic on routine pediatric vaccination in the United States. Specific study …
A new report examines how the COVID-19 pandemic affected the process of ordering and administering routine childhood vaccines in the United …
CDC
Apr 4, 2026
Pediatrics
Survey explores adolescent COVID-19 vaccination acceptance and influencing factors in US
What would make teens and parents more open to COVID-19 vaccination?
A US survey of adolescents and parents examined COVID-19 vaccination acceptance and factors that might increase adolescent vaccination. The …
A new survey asks teens and parents what information about COVID-19 vaccine safety and effectiveness would make them more willing to get the…
CDC
Apr 4, 2026
Pediatrics
Pediatric Emergency Visits Decreased During COVID-19 Pandemic, With COVID-19 Cases Predominating
Did fewer kids go to the ER during the pandemic? A new report suggests yes.
An observational report of U.S. emergency departments found pediatric visits decreased in 2020, 2021, and January 2022 compared to 2019, whi…
Overall pediatric emergency room visits dropped in 2020, 2021, and January 2022 compared to 2019, while COVID-19 cases became the main reaso…
CDC
Apr 4, 2026